生命科学资讯

With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis

Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic

Orion's €180M milestone payment; Iolyx partners dry eye candidate

Pfizer-allied molecular glue startup Triana collects $120M Series B

Pharvaris’ pill succeeds in late-stage trial for rare swelling disorder

From Mt. Fuji to the Lab Bench: A UW-Madison Student’s Summer in Japan

Morgan Stanley Initiates Coverage on Agilent Technologies (NYSE:A) - MarketBeat

Subcellular proteomics of the protist Paradiplonema papillatum reveals the digestive capacity of the cell membrane and the plasticity of peroxisomes across euglenozoans

Are we over-conserving charismatic species?

Thermo Fisher Scientific Expands Bioprocessing Capabilities Across Asia - Contract Pharma

Excelsior Sciences raises $95M for small molecule drug discovery, manufacturing

Hemophilia gene therapies are struggling on the market, even as innovation soars

4 major changes at the FDA this year

Chinese scientists divulge new XOR inhibitors

Zhimeng Biopharma describes new compounds to treat HBV infection

New TP53 stabilizers disclosed in Shanghai Qilu Pharmaceutical patent

Shenzhen Forward Pharmaceuticals discovers new FGFR2 inhibitors

Bristol Myers pushes back Cobenfy readout after trial site 'irregularities'

Updated: Pharvaris’ hereditary angioedema drug gets Phase 3 win

Why Agilent Technologies Inc. stock benefits from AI revolution - July 2025 Final Week & High Yield Stock Recommendations - Newser